Noteworthy, mutations in caspase-10 (70) or caspase-8 (71), both downstream of Fas and TRAIL-R signaling, result in immune dysregulation with features of autoimmune lymphoproliferative syndrome. Here, CASP8 is linked to autoimmune lymphoproliferative syndrome.